PARIS, Feb. 20, 2018 /PRNewswire/ — Johnson & Johnson Medical Devices Companies, through French affiliate Apsis S.A.S., announced today the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution. This proprietary technology is currently in early-stage development for total and partial knee replacement, and the Johnson & Johnson Medical Devices Companies […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone